Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma von Esnaola, Nestor F., Meyer, Joshua E., Karachristos, Andreas, Maranki, Jennifer L., Camp, E. Ramsay, Denlinger, Crystal S.

Volltext

Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed von Vijayvergia, Namrata, Denlinger, Crystal S

Volltext

American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control von PATEL, ALPA V, FRIEDENREICH, CHRISTINE M, MOORE, STEVEN C, HAYES, SANDRA C, SILVER, JULIE K, CAMPBELL, KRISTIN L, WINTERS-STONE, KERRI, GERBER, LYNN H, GEORGE, STEPHANIE M, FULTON, JANET E, DENLINGER, CRYSTAL, MORRIS, G STEPHEN, HUE, TRISHA, SCHMITZ, KATHRYN H, MATTHEWS, CHARLES E

Volltext

Pancreas Cancer‐Associated Weight Loss von Hendifar, Andrew E., Petzel, Maria Q.B., Zimmers, Teresa A., Denlinger, Crystal S., Matrisian, Lynn M., Picozzi, Vincent J., Rahib, Lola, Hendifar, Andrew, Tuli, Richard, Wolpin, Brian, Hidalgo, Manuel, Ryan, David, Hingorani, Sunil, Chiorean, Elena Gabriela, Coveler, Andrew, O'Reilly, Eileen, Balachandran, Vinod, Simeone, Diane, Lowy, Andrew, Fanta, Paul, Kurzrock, Razelle, Reid, Tony, Ko, Andrew, Collisson, Eric, Tempero, Margaret, Kindler, Hedy, George, Thomas, Trevino, Jose, Vonderheide, Robert, Beatty, Gregory, Picozzi, Vincent, Mandelson, Margaret, Wang‐Gillam, Andrea, Hawkins, William, Fleshman, Julie, Hidalgo, Manuel, Hingorani, Sunil, Maitra, Anirban, Manax, Victoria, Matrisian, Lynn, Picozzi, Vincent, Simeone, Diane

Volltext

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, place... von Fuchs, Charles S, Di Bartolomeo, Maria, Lonardi, Sara, Van Cutsem, Eric, Ilson, David H, Alsina, Maria, Chau, Ian, Lacy, Jill, Ducreux, Michel, Mendez, Guillermo Ariel, Alavez, Alejandro Molina, Takahari, Daisuke, Gorbounova, Vera, Wainberg, Zev A, Hegewisch-Becker, Susanna, Ferry, David, Lin, Ji, Das, Mayukh, Shah, Manish A, Karaseva, Nina A., Csoszi, Tibor, De Vita, Ferdinando, Sugimoto, Naotoshi, Kocsis, Judit, Csilla, Andràs, Bodoky, Gyorgy, Protsenko, Svetlana, Madi, Ayman, Wojcik, Elzbieta, Brenner, Baruch, Sarosiek, Tomasz, Peltola, Katriina Johanna, Bono, Peter, Aprile, Giuseppe, Falcone, Alfredo, Di Costanzo, Francesco, García Alfonso, Pilar, Senellart, Hélène, Petty, Russell, Samuel, Leslie, Hussein, Maen Abdelkarim, Won, Elizabeth, Bendell, Johanna Chock, Lorenzen, Sylvie, Melichar, Bohuslav, Pezet, Denis, Phelip, Jean-Marc, Kaen, Diego Lucas, Madhusudan, Srinivasan, Barone, Carlo, Fein, Luis Enrique, Gomez Villanueva, Angel, Prausova, Jana, Vidal Barrull, Joana, Yilmaz, Mette Karen Nytoft, DiCarlo, Brian Anthony, Geboes, Karen, Geva, Ravit, Kadowaki, Shigenori, Machida, Nozomu, Ramirez Godinez, Francisco Javier, Ruzsa, Agnes, Ford, Hugo, Lawler, William E., Petera, Jiri, Yamaguchi, Kensei, Hara, Hiroki, Beck, Joseph Thaddeus, Błasińska-Morawiec, Maria, Alcindor, Thierry, Bajaj, Madhuri, Berry, Scott, Dammrich, Daniel, Taieb, Julien, Ten Tije, A.J., Burkes, Ronald L., Cabanillas, Fernando, Firdaus, Irfan, Chua, Cynthia Coo, Hironaka, Shuichi, Hofheinz, Ralf-Dieter, Lim, Howard J., Nordsmark, Marianne, Verma, Udit, Wadsley, Jonathan, Yukisawa, Seigo, Pikiel, Joanna, Wojcik-Tomaszewska, Joanna, Brezden-Masley, Christine, Jang, Raymond Woo-Jun, Pribylova, Jana, Sakai, Daisuke, Bartoli, Maria Alejandra, Cats, A., Grootscholten, M.I., Dichmann, Robert Andrew, Hool, Hugo, Shaib, Walid, Tsuji, Akihito, Asmis, Timothy R.

Volltext

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials von Vijayvergia, Namrata, Dasari, Arvind, Deng, Mengying, Litwin, Samuel, Al-Toubah, Taymeyah, Alpaugh, R. Katherine, Dotan, Efrat, Hall, Michael J., Ross, Nicole M., Runyen, Melissa M., Denlinger, Crystal S., Halperin, Daniel M., Cohen, Steven J., Engstrom, Paul F., Strosberg, Jonathan R.

Volltext

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma von Kelly, Ronan J., Lee, Jeeyun, Bang, Yung-Jue, Almhanna, Khaldoun, Blum-Murphy, Mariela, Catenacci, Daniel V. T., Hyun Cheol Chung, Wainberg, Zev A., Gibson, Michael K., Lee, Keun-Wook, Bendell, Johanna C., Denlinger, Crystal S., Chee, Cheng Ean, Omori, Takeshi, Leidner, Rom, Lenz, Heinz-Josef, Chao, Yee, Rebelatto, Marlon C., Brohawn, Philip Z., He, Peng, McDevitt, Jennifer, Sheth, Siddharth, Englert, Judson M., Ku, Geoffrey Y.

Volltext

Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review von Stack, Anthony, Khanal, Rashmi, Denlinger, Crystal S.

Volltext

Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions von Jain, Rishi, Denlinger, Crystal S.

Volltext

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer von Dotan, Efrat, Cardin, Dana B., Lenz, Heinz-Josef, Messersmith, Wells, O'Neil, Bert, Cohen, Steven J., Denlinger, Crystal S., Shahda, Safi, Astsaturov, Igor, Kapoun, Ann M., Brachmann, Rainer K., Uttamsingh, Shailaja, Stagg, Robert J., Weekes, Colin

Volltext

A randomized trial of exercise and diet on health‐related quality of life in survivors of breast cancer with overweight or obesity von Brown, Justin C., Sarwer, David B., Troxel, Andrea B., Sturgeon, Kathleen, DeMichele, Angela M., Denlinger, Crystal S., Schmitz, Kathryn H.

Volltext

Optimal post-treatment surveillance in cancer survivors: is more really better? von Shah, Megha, Denlinger, Crystal S

Volltext

Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors von Denlinger, Crystal S., Keedy, Vicki L., Moyo, Victor, MacBeath, Gavin, Shapiro, Geoffrey I.

Volltext

A randomized trial of exercise and diet on body composition in survivors of breast cancer with overweight or obesity von Brown, Justin C., Sarwer, David B., Troxel, Andrea B., Sturgeon, Kathleen, DeMichele, Angela M., Denlinger, Crystal S., Schmitz, Kathryn H.

Volltext

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors von Zibelman, Matthew, MacFarlane, Alexander W., Costello, Kimberly, McGowan, Thomas, O’Neill, John, Kokate, Rutika, Borghaei, Hossein, Denlinger, Crystal S., Dotan, Efrat, Geynisman, Daniel M., Jain, Angela, Martin, Lainie, Obeid, Elias, Devarajan, Karthik, Ruth, Karen, Alpaugh, R. Katherine, Dulaimi, Essel Al-Saleem, Cukierman, Edna, Einarson, Margret, Campbell, Kerry S., Plimack, Elizabeth R.

Volltext

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2... von Valle, Juan W, Vogel, Arndt, Denlinger, Crystal S, He, Aiwu Ruth, Bai, Li-Yuan, Orlova, Rashida, Van Cutsem, Eric, Adeva, Jorge, Chen, Li-Tzong, Obermannova, Radka, Ettrich, Thomas J, Chen, Jen-Shi, Wasan, Harpreet, Girvan, Allicia C, Zhang, Wei, Liu, Jiangang, Tang, Chunlao, Ebert, Philip J, Aggarwal, Amit, McNeely, Samuel C, Moser, Brian A, Oliveira, Joana M, Carlesi, Roberto, Walgren, Richard A, Oh, Do-Youn

Volltext

Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors von Balmanoukian, Ani S., Infante, Jeffrey R., Aljumaily, Raid, Naing, Aung, Chintakuntlawar, Ashish V., Rizvi, Naiyer A., Ross, Helen J., Gordon, Michael, Mallinder, Philip R., Elgeioushi, Nairouz, Gonzalez-Garcia, Ignacio, Standifer, Nathan, Cann, Jennifer, Durham, Nicholas, Rahimian, Shahram, Kumar, Rakesh, Denlinger, Crystal S.

Volltext

The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors von Brown, Justin C., Sturgeon, Kathleen, Sarwer, David B., Troxel, Andrea B., DeMichele, Angela M., Denlinger, Crystal S., Schmitz, Kathryn H.

Volltext

First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer von He, Aiwu Ruth, Cohen, Roger B., Denlinger, Crystal S., Sama, Ashwin, Birnbaum, Ariel, Hwang, Jimmy, Sato, Takami, Lewis, Nancy, Mynderse, Michelle, Niland, Michele, Giles, Jennifer, Wallin, Johan, Moser, Brian, Zhang, Wei, Walgren, Richard, Plimack, Elizabeth R.

Volltext

Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-cell Engager That Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas von Pishvaian, Michael, MD, PhD, Morse, Michael A., MD, McDevitt, Jennifer, PharmD, PhD, Norton, Jonathan D, Ren, Song, PhD, Robbie, Gabriel J., PhD, Ryan, Patricia C., PhD, Soukharev, Serguei, PhD, Bao, Haifeng, PhD, Denlinger, Crystal S., MD

Volltext